Taisho Pharmaceutical (TAIPY) Stock Price, News & Analysis

Company Overview

Taisho Pharmaceutical Holdings Co., Ltd. is a Japanese healthcare company focused on over-the-counter medicines, prescription pharmaceuticals, and health-related products. Through its businesses, the company develops, manufactures, and markets treatments and consumer healthcare products intended to address common illnesses, support wellness, and improve quality of life.

Its consumer healthcare portfolio has included well-known Japanese brands such as Lipovitan energy drinks, Pabron cold remedies, RiUP hair-growth treatments, and Colac gastrointestinal products. The company has also marketed products under the Vicks brand in Japan and has operated in prescription pharmaceuticals, including medicines for infectious diseases and other therapeutic areas.

Taisho Pharmaceutical traces its history to 1912 and has expanded beyond Japan through subsidiaries and partnerships serving markets in Asia and other international regions. The company was reorganized under Taisho Pharmaceutical Holdings in 2011, creating a holding structure for its pharmaceutical and consumer healthcare operations. In 2024, Taisho Pharmaceutical Holdings became a subsidiary of Otsuka Holdings following Otsuka's acquisition of the company.

Key Stats

• Today's Range: $14.00 to $14.00
• 50-Day Range: $14.00 to $14.00
• 52-Week Range: $8.88 to $15.52
• Volume: N/A
• Average Volume: 1,958 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TAIPY
• CIK: 1716957
• Web: www.taisho-holdings.co.jp
• Phone: (133) 985-2020
• Fax: N/A
• Employees: 8,784
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A